474 related articles for article (PubMed ID: 11381089)
1. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.
Gottardi CJ; Wong E; Gumbiner BM
J Cell Biol; 2001 May; 153(5):1049-60. PubMed ID: 11381089
[TBL] [Abstract][Full Text] [Related]
2. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin.
Wong AS; Gumbiner BM
J Cell Biol; 2003 Jun; 161(6):1191-203. PubMed ID: 12810698
[TBL] [Abstract][Full Text] [Related]
3. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions.
Gottardi CJ; Gumbiner BM
Am J Physiol Cell Physiol; 2004 Apr; 286(4):C747-56. PubMed ID: 14613891
[TBL] [Abstract][Full Text] [Related]
4. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes.
Gottardi CJ; Gumbiner BM
J Cell Biol; 2004 Oct; 167(2):339-49. PubMed ID: 15492040
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.
Persad S; Troussard AA; McPhee TR; Mulholland DJ; Dedhar S
J Cell Biol; 2001 Jun; 153(6):1161-74. PubMed ID: 11402061
[TBL] [Abstract][Full Text] [Related]
7. Requirement for a nuclear function of beta-catenin in Wnt signaling.
Cong F; Schweizer L; Chamorro M; Varmus H
Mol Cell Biol; 2003 Dec; 23(23):8462-70. PubMed ID: 14612392
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
9. Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin.
Sasaki CY; Lin H; Morin PJ; Longo DL
Cancer Res; 2000 Dec; 60(24):7057-65. PubMed ID: 11156412
[TBL] [Abstract][Full Text] [Related]
10. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
[TBL] [Abstract][Full Text] [Related]
12. Regulation of beta -catenin transformation by the p300 transcriptional coactivator.
Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression.
Prieve MG; Waterman ML
Mol Cell Biol; 1999 Jun; 19(6):4503-15. PubMed ID: 10330189
[TBL] [Abstract][Full Text] [Related]
14. Signalling activity of beta-catenin targeted to different subcellular compartments.
Hagen T; Sethi JK; Foxwell N; Vidal-Puig A
Biochem J; 2004 Apr; 379(Pt 2):471-7. PubMed ID: 14733614
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
16. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
17. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
18. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin.
Simcha I; Shtutman M; Salomon D; Zhurinsky J; Sadot E; Geiger B; Ben-Ze'ev A
J Cell Biol; 1998 Jun; 141(6):1433-48. PubMed ID: 9628899
[TBL] [Abstract][Full Text] [Related]
19. Exchange of catenins in cadherin-catenin complex.
Klingelhöfer J; Troyanovsky RB; Laur OY; Troyanovsky S
Oncogene; 2003 Feb; 22(8):1181-8. PubMed ID: 12606944
[TBL] [Abstract][Full Text] [Related]
20. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
